Literature DB >> 17453904

Creative thinking in schizophrenia: the role of executive dysfunction and symptom severity.

Anna Abraham1, Sabine Windmann, Peter McKenna, Onur Güntürkün.   

Abstract

INTRODUCTION: This study examines the notion of enhanced creative thinking in schizophrenia and determines the mediating role of executive dysfunction and symptom severity in this relationship.
METHOD: Patients with chronic schizophrenia (n=28) were assessed on varied facets of creative cognition and standard tests of executive control relative to matched healthy control participants (n=18).
RESULTS: Multivariate analyses revealed poorer performance by the patient group across almost all creative and executive function measures, except in the ability to be unconstrained by the influence of restrictive examples. Symptom-based contrasts using partial correlations revealed that differences were most extensive in the presence of thought disorder. Using hierarchical regression analyses, performance on the executive function tasks was found to play a mediatory role on specific aspects of creative cognition.
CONCLUSIONS: Results are at odds with the popular notion of enhanced creative thinking in schizophrenia, but elucidate complex interactions between executive control and certain facets of creative thinking. In particular, performance of the schizophrenia group on measures that tap creativity elements of fluency and relevance were either partially or fully mediated by their performance on the executive control tasks, but this was not true of measures of originality.

Entities:  

Mesh:

Year:  2007        PMID: 17453904     DOI: 10.1080/13546800601046714

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  18 in total

Review 1.  Weakness of will, akrasia, and the neuropsychiatry of decision making: an interdisciplinary perspective.

Authors:  Annemarie Kalis; Andreas Mojzisch; T Sophie Schweizer; Stefan Kaiser
Journal:  Cogn Affect Behav Neurosci       Date:  2008-12       Impact factor: 3.282

Review 2.  Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius.

Authors:  Tiffany A Greenwood
Journal:  Mol Neuropsychiatry       Date:  2016-12-09

3.  Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS.

Authors:  D W Meechan; H L H Rutz; M S Fralish; T M Maynard; L A Rothblat; A-S LaMantia
Journal:  Cereb Cortex       Date:  2013-11-11       Impact factor: 5.357

4.  Neuropsychological differentiation of adaptive creativity and schizotypal cognition.

Authors:  Joscelyn E Fisher; Wendy Heller; Gregory A Miller
Journal:  Pers Individ Dif       Date:  2013-01

5.  Creativity and schizotypy from the neuroscience perspective.

Authors:  Andreas Fink; Bernhard Weber; Karl Koschutnig; Gernot Reishofer; Franz Ebner; Ilona Papousek; Elisabeth M Weiss
Journal:  Cogn Affect Behav Neurosci       Date:  2014-03       Impact factor: 3.526

6.  Creative thinking as orchestrated by semantic processing vs. cognitive control brain networks.

Authors:  Anna Abraham
Journal:  Front Hum Neurosci       Date:  2014-02-24       Impact factor: 3.169

7.  The promises and perils of the neuroscience of creativity.

Authors:  Anna Abraham
Journal:  Front Hum Neurosci       Date:  2013-06-05       Impact factor: 3.169

8.  The association between creativity and 7R polymorphism in the dopamine receptor D4 gene (DRD4).

Authors:  Naama Mayseless; Florina Uzefovsky; Idan Shalev; Richard P Ebstein; Simone G Shamay-Tsoory
Journal:  Front Hum Neurosci       Date:  2013-08-26       Impact factor: 3.169

9.  The structure of creative cognition in the human brain.

Authors:  Rex E Jung; Brittany S Mead; Jessica Carrasco; Ranee A Flores
Journal:  Front Hum Neurosci       Date:  2013-07-08       Impact factor: 3.169

10.  Exceptional visuospatial imagery in schizophrenia; implications for madness and creativity.

Authors:  Taylor L Benson; Sohee Park
Journal:  Front Hum Neurosci       Date:  2013-11-11       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.